NexgenRx Inc.
NXG.V
TSX
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Net Income | 189.70K | -17.20K | -46.90K | -244.70K | -229.30K |
Total Depreciation and Amortization | 933.30K | 946.30K | 961.30K | 969.10K | 983.50K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 47.50K | 51.90K | 51.20K | 53.20K | 155.70K |
Change in Net Operating Assets | -451.30K | 169.60K | -76.20K | 172.60K | -608.10K |
Cash from Operations | 719.40K | 1.15M | 889.50K | 950.30K | 301.80K |
Capital Expenditure | -50.50K | -84.60K | -66.30K | -57.30K | 195.10K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -168.50K | -124.80K | -158.70K | -127.50K | -137.90K |
Cash from Investing | -219.00K | -209.40K | -225.00K | -184.80K | 57.30K |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -98.60K | -89.40K | -82.60K | -79.20K | -78.80K |
Issuance of Common Stock | 187.50K | 187.50K | 187.50K | 62.50K | 62.50K |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -639.70K | -640.10K | -667.70K | -667.60K | -384.20K |
Other Financing Activities | 0.00 | 33.00K | -- | -- | -- |
Cash from Financing | -573.70K | -542.60K | -589.60K | -679.70K | -396.00K |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -73.50K | 398.50K | 74.60K | 85.50K | -37.20K |